PomegraStryker Stock Falls 12% After Earnings Miss, Guidance Cut
Why is Stryker stock down today?
Stryker (SYK) stock fell about 12% to $275 in after-hours trading on Thursday after an earnings miss and a cut to its 2026 profit outlook tied to slower hip and knee surgeries.
Key numbers
| After-hours move | -11.8%$274.97 vs $311.75 close; some reports say 13% |
|---|---|
| Q3 adjusted EPS | $3.52+10.3% YoY, vs $3.55 expected |
| Q3 net sales | $6.5B+7.7% YoY |
| 2026 adjusted EPS outlook | $14.80–$14.90from $14.95–$15.10 |
| 2026 organic sales growth outlook | 6.5%–7.0%from 8.3%–9.3% |
What happened
Stryker (SYK) stock fell about 12% to $275 in after-hours trading on Thursday after an earnings miss and a cut to its 2026 profit outlook tied to slower hip and knee surgeries. Stryker makes joint implants, surgical robots and hospital equipment. Its adjusted profit was $3.52 a share, just under the $3.55 analysts expected, while sales rose 7.7% to $6.5 billion. The company now expects 2026 profit of $14.80 to $14.90 a share, down from $14.95 to $15.10. Management blamed fewer hip and knee procedures as patients face higher costs, plus supply problems in blood-vessel products.
Why it matters
Stryker is one of the biggest makers of hip and knee implants, so its warning suggests fewer people are choosing joint surgery as health costs rise. Management now sees the U.S. hip and knee market growing only about 2.5% this year, well below recent years. Shareholders saw the stock drop from a $311.75 close to about $275 in after-hours trading, a move that can change once regular trading opens.
Who this affects
- MarketbearishMedium impact
- Health-care investors get a warning on slowing surgery demand.
- CompanybearishHigh impact
- Shareholders lost about 12% after hours as profit outlook fell.
- CompetitorsmixedLow impact
- Zimmer Biomet slipped 2.8% after hours; Medtronic edged up.
- IndustrybearishMedium impact
- Hip and knee market now seen growing only about 2.5%.
Stryker vs Zimmer Biomet, Boston Scientific, Medtronic
How we got here
Stryker reports Q2 and guides 2026 adjusted EPS to $14.95–$15.10
Stryker reports Q3 EPS of $3.52 and cuts 2026 outlook to $14.80–$14.90
Shares close at $311.75, then fall about 11.8% to $274.97 after hours
What to watch
- Stryker's first regular-session trading after the after-hours drop to about $2752026-10-30
- Fourth-quarter results; management expects organic growth similar to Q3's 7.7%Q1 2027
- Pace of the new $3.0 billion share repurchase increase approved by the boardQ4 2026
Educational content only. Not investment advice.
More briefsAll briefs →
Illumina Stock Falls 12% After Hours on Revenue Miss
Illumina (ILMN) beat profit forecasts at $1.44 a share, but weak lab spending and flat China sales hurt.
Roblox Stock Falls 18% After Weak Guidance
Roblox (RBLX) slid as users fell 9% despite 16% revenue growth; Reddit, Twilio and Pinterest also dropped.
Yen Rises to 157.12 Per Dollar as BOJ Signals More Hikes
Bank of Japan held at 1.25% on an 8–1 vote and lifted its fiscal 2027 inflation forecast to 2.6% (USD/JPY).